On August 6, President Trump signed an Executive Order, Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States, designed to reduce U.S. dependency on foreign sources of...more
Editor’s Note: This “Manatt on Medicaid” is the fifth in a series of updates focused on CMS’s new Medicaid/CHIP managed care regulations. In the coming weeks Manatt will continue to explore key provisions of the regulations...more
As the Healthcare Landscape Shifts, Four Issues Are Critical to Build Effective Market Access Strategies -
In this time of high growth and fast change for the healthcare industry, pharmaceutical, biotechnology and...more
8/20/2013
/ Affordable Care Act ,
Biotechnology ,
Compliance ,
False Claims Act (FCA) ,
Fraud ,
Health Insurance Exchanges ,
Healthcare ,
Insurance Industry ,
Manufacturers ,
Medical Devices ,
Penalties ,
Pharmaceutical Industry ,
Premiums ,
Prescription Drugs ,
Reimbursements